Hyperion Defi (HYPD) Total Liabilities (2016 - 2026)
Hyperion Defi (HYPD) posted quarterly Total Liabilities of $11.6 million for Q1 2026, down 26.29% year-over-year from $15.7 million in Q1 2025, and up 8.1% quarter-over-quarter from $10.7 million in Q4 2025.
Hyperion Defi (HYPD) Total Liabilities (2016 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Total Liabilities for 11 consecutive years, with $11.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 26.29% year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $11.6 million (down 26.29% YoY), while the FY2025 annual figure was $10.7 million, down 36.15% from the prior year.
- Total Liabilities advanced to $11.6 million in Q1 2026 per HYPD's latest filing, from $10.7 million in the prior quarter.
- Across five years, Total Liabilities topped out at $24.4 million in Q1 2024 and bottomed at $10.4 million in Q1 2022.
- Historically, Total Liabilities has averaged $15.8 million across 5 years, with a median of $15.7 million in 2025.
- Annual changes were most pronounced in 2022 — Total Liabilities tumbled 46.61% — and 2024, when it jumped 80.5%.
- Hyperion Defi's Total Liabilities stood at $13.8 million in 2022, then jumped by 43.32% to $19.8 million in 2023, then dropped by 15.25% to $16.8 million in 2024, then sank by 36.15% to $10.7 million in 2025, then advanced by 8.1% to $11.6 million in 2026.
- Business Quant data shows HYPD's Total Liabilities at $11.6 million in Q1 2026, $10.7 million in Q4 2025, and $12.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 10.03 Bn |
| 10 | Hyperion Defi | 45.36 Mn | 35.72 Mn | 357,693.00 | 11.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.20 Mn |
| Mar 31, 2026 | 11.57 Mn |
| Dec 31, 2025 | 10.70 Mn |
| Sep 30, 2025 | 12.03 Mn |
| Jun 30, 2025 | 18.30 Mn |
| Mar 31, 2025 | 15.70 Mn |
| Dec 31, 2024 | 16.76 Mn |
| Sep 30, 2024 | 19.08 Mn |
| Jun 30, 2024 | 21.36 Mn |
| Mar 31, 2024 | 24.36 Mn |
| Dec 31, 2023 | 19.78 Mn |
| Sep 30, 2023 | 19.09 Mn |
| Jun 30, 2023 | 18.82 Mn |
| Mar 31, 2023 | 13.50 Mn |
| Dec 31, 2022 | 13.80 Mn |
| Sep 30, 2022 | 11.08 Mn |
| Jun 30, 2022 | 12.00 Mn |
| Mar 31, 2022 | 10.39 Mn |
| Dec 31, 2021 | 11.19 Mn |
| Sep 30, 2021 | 20.75 Mn |